
Context Therapeutics Inc. (CNTX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
2.2600 - Open
2.2600 - Bid 1.6300 x 200
- Ask 2.8100 x 200
- Day's Range
2.1700 - 2.3100 - 52 Week Range
0.4900 - 3.6200 - Volume
811,470 - Avg. Volume
1,173,639 - Market Cap (intraday)
203.053M - Beta (5Y Monthly) 1.83
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.00
Recent News: CNTX
View MorePerformance Overview: CNTX
Trailing total returns as of 4/27/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: CNTX
View MoreAnalyst Insights: CNTX
View MoreStatistics: CNTX
View MoreValuation Measures
-
Market Cap
207.65M
-
Enterprise Value
141.76M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
3.43
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-29.79%
-
Return on Equity (ttm)
-46.39%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-36.12M
-
Diluted EPS (ttm)
-0.3800
Balance Sheet and Cash Flow
-
Total Cash (mrq)
66M
-
Total Debt/Equity (mrq)
0.19%
-
Levered Free Cash Flow (ttm)
-19.13M
Compare To: CNTX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.



